Dr, Ted Cassidy was recently featured in the Australian Financial Review discussing the impact of the Therapeutic Goods Administration's recent decision to approve psychedelics.
Like medicinal cannabis before it, psychedelics have won TGA approval via lobbying by consumer and business groups, well before there are scientific guidelines for clinical use.
Read the full story here.